Evidence map›Paper›PMID 33831416›Full record

ArticleThe Journal of biological chemistry

The uncharacterized SANT and BTB domain-containing protein SANBR inhibits class switch recombination.

Simin Zheng, Allysia J Matthews, Numa Rahman, Kayleigh Herrick-Reynolds, Emily Sible, Jee Eun Choi, Alec Wishnie, Yan Kee Ng, Daniela Rhodes, Stephen J Elledge and 1 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Simin ZhengDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA; NTU Institute of Structural Biology, Nanyang Technological University, Singapore, Singapore.
Allysia J MatthewsYale School of Medicine, Yale University, New Haven, Connecticut, USA; Department of Biology, The Graduate Center and The City College of New York, New York, New York, USA.
Numa RahmanImmunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Kayleigh Herrick-ReynoldsImmunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Emily SibleDepartment of Biology, The Graduate Center and The City College of New York, New York, New York, USA.
Jee Eun ChoiDepartment of Biology, The Graduate Center and The City College of New York, New York, New York, USA.
Alec WishnieDepartment of Biology, The Graduate Center and The City College of New York, New York, New York, USA.
Yan Kee NgNTU Institute of Structural Biology, Nanyang Technological University, Singapore, Singapore.
Daniela RhodesNTU Institute of Structural Biology, Nanyang Technological University, Singapore, Singapore.
Stephen J ElledgeDepartment of Genetics, Program in Virology, Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts, USA; Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Bao Q VuongDepartment of Biology, The Graduate Center and The City College of New York, New York, New York, USA. Electronic address: bvuong@ccny.cuny.edu.
The Graduate Center, CUNY · USNanyang Technological University · SGMemorial Sloan Kettering Cancer Center · USBrigham and Women's Hospital · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Training and Career Development CoreU54CA132378 · NCI · CITY COLLEGE OF NEW YORK · PI Carlos Riobó · 2008 to 2026
$28.9M
Training and Career Development and Education CoreU54CA137788 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ADRIANA ESPINOSA, FRANCESCA M GANY · 2008 to 2026
$28.1M
Cellular/Molecular Basis of Development: Research CenterG12MD007603 · NIMHD · CITY COLLEGE OF NEW YORK · PI PEZZANO, MARK · 2012 to 2017
$11.5M
Molecular Mechanisms Regulating Immunoglobulin DiversificationSC1GM132035 · NIGMS · CITY COLLEGE OF NEW YORK · PI VUONG, BAO Q · 2019 to 2022
$1.6M
NCI NIH HHS P30 CA008748NCI NIH HHS U54 CA132378NCI NIH HHS U54 CA137788NIGMS NIH HHS SC1 GM132035NIMHD NIH HHS G12 MD007603
6 · The paper itself

Abstract

Class switch recombination (CSR) is the process by which B cells switch production from IgM/IgD to other immunoglobulin isotypes, enabling them to mount an effective immune response against pathogens. Timely resolution of CSR prevents damage due to an uncontrolled and prolonged immune response. While many positive regulators of CSR have been described, negative regulators of CSR are relatively unknown. Using an shRNA library screen targeting more than 28,000 genes in a mouse B cell line, we have identified a novel, uncharacterized protein of 82kD (KIAA1841, NM_027860), which we have named SANBR (SANT and BTB domain regulator of CSR), as a negative regulator of CSR. The purified, recombinant BTB domain of SANBR exhibited characteristic properties such as homodimerization and interaction with corepressor proteins, including HDAC and SMRT. Overexpression of SANBR inhibited CSR in primary mouse splenic B cells, and inhibition of CSR is dependent on the BTB domain while the SANT domain is largely dispensable. Thus, we have identified a new member of the BTB family that serves as a negative regulator of CSR. Future investigations to identify transcriptional targets of SANBR in B cells will reveal further insights into the specific mechanisms by which SANBR regulates CSR as well as fundamental gene regulatory activities of this protein.

Indexed as

BTB-POZ DomainImmunoglobulin Class SwitchingRecombination, GeneticAmino Acid SequenceAnimalsB-LymphocytesDNA-Binding ProteinsFemaleHumansLymphoma, B-CellMaleMiceMice, Inbred C57BLRNA, Small InterferingSequence HomologyDNA-Binding ProteinsRNA, Small InterferingB cellscorepressorDNA recombinationimmunoglobulin diversification

Identifiers

PMID33831416
PMCPMC8141524
OpenAlexW3144440713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.